Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,287.60
(
-0.25%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.94
(
-0.50%
)
Bitcoin
76,943.11
(
-0.60%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

goodJohnhunting

Send PM Follow Ignore
Followers 35
Posts 1202
Boards Moderated 1
Alias Born 08/27/2000

goodJohnhunting

Member Level

Re: geocappy1 post# 305613

Thursday, 07/27/2017 10:11:16 AM

Thursday, July 27, 2017 10:11:16 AM

Post# of 347009

GJH

You keep saying that bavi is a clumsy molecule. Would BBs be better in your opinion and if so why do you think they are not choosing to get it out there.



BB's will not change the "elephant in the room" (Endogenous Protein Cross Reactivity), IMO.

Chemo produces more competition for anti-ps and thus the laws of diminishing returns. What needs to happen is a reduction in receptor site competition. In one such theory, statins would eliminate "marginal" competition, IMO.

The question is how much is marginal, and what therapeutic significance would be achieved?

All the best,
John

Disclaimer: Every post, and all my views are only speculative. Do not invest money or any other resources based on these post or opinions. Best of luck and do your own due diligence!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote